X-48904764-G-A
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_005660.3(SLC35A2):c.1145C>T(p.Thr382Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000019 in 1,209,770 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T382T) has been classified as Likely benign.
Frequency
Consequence
NM_005660.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC35A2 | NM_005660.3 | c.1145C>T | p.Thr382Met | missense_variant | 4/5 | ENST00000247138.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC35A2 | ENST00000247138.11 | c.1145C>T | p.Thr382Met | missense_variant | 4/5 | 1 | NM_005660.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000447 AC: 5AN: 111802Hom.: 0 Cov.: 24 AF XY: 0.0000588 AC XY: 2AN XY: 33986
GnomAD3 exomes AF: 0.0000767 AC: 14AN: 182578Hom.: 0 AF XY: 0.0000894 AC XY: 6AN XY: 67124
GnomAD4 exome AF: 0.0000164 AC: 18AN: 1097917Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 5AN XY: 363285
GnomAD4 genome AF: 0.0000447 AC: 5AN: 111853Hom.: 0 Cov.: 24 AF XY: 0.0000587 AC XY: 2AN XY: 34047
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 10, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
SLC35A2-congenital disorder of glycosylation Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 18, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at